KAV.L

Kavango Resources plc
Kavango Resources - Issue of Loan Notes & Strategic Financing Increase
19th December 2024, 18:31
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8410Q
Kavango Resources PLC
19 December 2024
 

19 December 2024

Kavango Resources PLC

("Kavango" or "the Company")

Issue of Loan Notes & Strategic Financing Increase

 

Kavango Resources plc (LSE:KAV), the Southern Africa-focused metals exploration company, is pleased to announce it has secured £1,511,668 through the issue of two Convertible Loan Notes ("CLNs").

Convertible Loan Note

Deputy Chairman Peter Wynter Bee has agreed to advance the Company £1,000,000 for one of the CLNs. Purebond, the Company's major shareholder, has advanced the Company £511,668 in the second of the CLNs.

The CLNs carry an annual coupon of 10% and have a twelve-month term. The CLNs and accrued interest are convertible into ordinary shares in the Company subject to publication of a prospectus. 

The Company has drafted a prospectus which is currently undergoing review by the Financial Conduct Authority (the "Prospectus"). Kavango intends to convert the principal of the CLNs into 215,952,571 new ordinary shares in the Company at a price of 0.7p per share, on publication of the Prospectus as part of the Strategic Financing announced this morning (announced >>> 19 December 2024) (the "Strategic Financing").

Outstanding Convertible Loans

Kavango previously entered into two Convertible Loan Notes (announced >>> 29 August 2024 & announced >>> 16 September 2024) (the "Outstanding CLNs"). The Company declared its expectation to convert both loan notes on publication of the Prospectus. Kavango now expects to convert the Outstanding CLNs on the same terms as the CLNs. The principal of the Outstanding CLNs is £2,200,000 and the Company intends to convert this into 314,285,714 new ordinary shares in the Company at a price of 0.7p per share, on publication of the Prospectus.

Kavango intends to use the published Prospectus as the listing document for application to trading of the Company's ordinary shares on the Victoria Falls Stock Exchange (announced >>> 02 August 2024).

Increase in Strategic Financing

The conversion of the CLNs and Outstanding CLNs will be in addition to the amount announced in the Strategic Financing. The total value of the Strategic Financing is now £10,277,868.

 

Further information in respect of the Company and its business interests is provided on the Company's website at www.kavangoresources.com and on Twitter at #KAV.

For further information please contact:

Kavango Resources plc                                                                                     

Ben Turney

+46 7697 406 06

First Equity (Broker)

+44 207 374 2212

Jason Robertson          

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODZZMMZRLKGDZM]]>
TwitterFacebookLinkedIn